PPARA and heart failure: Recently, using a mouseheart failure model and hypoxic-reoxygenated H9c2 cells, ginsenoside Rb3 wasidentified as potentially having the best pharmacodynamic profile in terms ofexerting cardiac protection against indices of heart failure, exerting thesalutary effects primarily via PPARα activation [35].